View Full Company Profile

Exzeo Group, Inc.

CIK: 1873951 Filed: February 26, 2026 10-K

Key Highlights

  • Successfully completed its Initial Public Offering (IPO) late in 2025, listing on the NYSE under ticker XZO.
  • Achieved strong revenue growth of 25% to $150 million in 2025, driven by expanding MGA partnerships and technology adoption.
  • Strategically investing in technology and market expansion as an Emerging Growth Company, aiming for long-term growth despite a net loss.
  • Leverages a proprietary InsurTech platform and MGA model for competitive advantage in product development and distribution.

Financial Analysis

Exzeo Group, Inc. 2025 Annual Review: A New Public Company's First Look

This summary provides a comprehensive overview of Exzeo Group, Inc.'s 2025 Annual Review (10-K filing). The fiscal year ending December 31, 2025, was transformative for Exzeo, as the company successfully completed its Initial Public Offering (IPO) late in the year. Exzeo's shares now trade on the New York Stock Exchange (NYSE) under the ticker symbol XZO, making it accessible to public investors.


Business Overview

Exzeo: Powering Insurance with Technology (InsurTech)

Exzeo operates as an "InsurTech" company, using technology to modernize and improve the insurance industry. The company enhances how insurers design products, assess risks (underwriting), distribute policies, and process claims.

Exzeo's core business activities include:

  • Underwriting and Management Services: As a "Managing General Agent" (MGA), Exzeo performs essential operational functions for insurance carriers, such as issuing policies, collecting premiums, and managing risk.
  • Claim Services: Through its specialized entities, Griston Claim Management and Griston Claim Services, Exzeo efficiently manages insurance claims.
  • Technology Solutions: Exzeo develops and implements advanced technology to support its services. This includes AI-powered tools for risk assessment, cloud-based platforms for streamlined claims processing, and data analytics for fraud detection and managing large-scale events like catastrophe responses.

Financial Performance

2025 Financial Highlights

Exzeo's financial results for the fiscal year ended December 31, 2025, show:

  • Revenue: The company generated approximately $150 million in revenue, a strong 25% increase from $120 million in 2024. This growth demonstrates the success of its expanding MGA partnerships and technology adoption.
  • Net Loss: Exzeo reported a net loss of approximately $20 million, an improvement from a $30 million net loss in 2024. As an Emerging Growth Company, Exzeo strategically prioritizes investment in technology and market expansion over immediate profitability.

Key Risk Factors

Investors should consider the following important risks:

  • Customer Concentration: Exzeo generates a significant portion of its revenue from a limited number of clients. In 2025, its largest customer ("Customer One") contributed approximately 35% of total revenue, and the top two customers combined accounted for about 50%. While this can reflect strong client relationships, losing a major client could materially impact Exzeo's financial performance. The company is actively working to diversify its client base.
  • Related Party Dealings: Exzeo maintains notable financial ties with HCI Group, Inc. (HCI), which owns approximately 40% of Exzeo. As of December 31, 2025, Exzeo owed HCI $50 million in outstanding notes payable, carrying a 5% interest rate and maturing in 2028. Exzeo closely monitors these dealings to ensure they occur at arm's length.
  • Broader Industry and Operational Risks: Like other InsurTech companies, Exzeo faces risks common to the sector. These include:
    • Intense competition
    • Evolving regulatory environments
    • Technological obsolescence
    • Cybersecurity threats
    • Reliance on third-party service providers
    • Ability to attract and retain key personnel
    • Intellectual property protection
    • General economic conditions Exzeo's 10-K provides further details on these and other factors that could materially affect its business, financial condition, and operational results.

Management Discussion & Analysis (MD&A) Highlights

Key Developments and Strategic Focus

  • IPO Proceeds: Exzeo is strategically deploying the capital raised from its IPO to accelerate technology development, expand its MGA network, and explore new insurance verticals.
  • Business Streamlining: In the third quarter of 2025, Exzeo successfully sold TTIC, a segment previously classified as discontinued operations. This strategic divestiture, which generated a modest gain, allows Exzeo to sharpen its focus and resources on its core InsurTech and MGA businesses.
  • International Presence: Exzeo operates in India, primarily for technology development and back-office support, leveraging global talent to enhance its service offerings.
  • Investment in Growth: The reported net loss reflects the company's strategic decision, as an Emerging Growth Company, to prioritize significant investments in technology and market expansion. This strategy aims to drive long-term growth and market penetration.

Financial Health

  • Cash Position: The IPO significantly strengthened Exzeo's balance sheet, providing substantial cash reserves. These funds will fuel future growth initiatives and technology development, boosting the company's liquidity.
  • Debt: As of December 31, 2025, Exzeo held $50 million in outstanding notes payable to HCI Group, Inc. These notes carry a 5% interest rate and mature in 2028, forming a key part of the company's long-term financing structure.

Future Outlook

Exzeo's management is focused on the future, aiming to leverage its technological edge to expand MGA partnerships, enhance its proprietary InsurTech platform, and strategically enter new insurance markets. The company plans to continue improving operational efficiencies and driving revenue growth while progressing towards sustained profitability. Investors should monitor Exzeo's ability to diversify its customer base and effectively deploy IPO proceeds to achieve these strategic objectives.


Competitive Position

Exzeo operates within a highly competitive and rapidly evolving InsurTech market. Its competitive advantages include:

  • Proprietary Technology Platform: This platform integrates AI-powered risk assessment, cloud-based claims processing, and advanced data analytics.
  • MGA Model: Exzeo's Managing General Agent (MGA) model enables it to quickly develop and distribute specialized insurance products, using its technology to boost efficiency and underwriting precision.

Exzeo competes against traditional insurance carriers, other InsurTech startups, and technology providers serving the insurance industry. The market features continuous innovation, consolidation, and the emergence of new players. Exzeo's sustained competitive edge will depend on its ongoing investment in technology, its ability to attract and retain talent, and its success in expanding MGA partnerships and its client base.


Additional Company Information

  • Company Status: Exzeo holds the classification of an "Emerging Growth Company" (EGC) and a "non-accelerated filer." This status grants the company certain regulatory flexibilities, suchs as reduced reporting requirements, potentially leading to less detailed disclosures compared to larger, more established public companies.
  • Shares Outstanding: As of February 20, 2026, Exzeo had approximately 90.9 million shares of its common stock outstanding.

Risk Factors

  • Significant customer concentration, with the largest customer contributing 35% and top two customers 50% of total revenue.
  • Material related party dealings with HCI Group, Inc., which owns 40% of Exzeo and is owed $50 million in outstanding notes payable.
  • Exposure to intense competition, evolving regulatory environments, technological obsolescence, and cybersecurity threats common to the InsurTech sector.

Why This Matters

Exzeo's 2025 Annual Review is particularly significant for investors as it marks the company's first public filing following its late-year IPO. This report offers the initial transparent look into the financial health and strategic direction of a newly public InsurTech player. For investors, understanding Exzeo's foundational year as a public entity is crucial for assessing its long-term potential, especially given its strategic prioritization of growth and market expansion over immediate profitability, a common characteristic of Emerging Growth Companies.

The report highlights Exzeo's strong revenue growth of 25% to $150 million, demonstrating successful execution in expanding MGA partnerships and technology adoption. However, the reported net loss of $20 million, while an improvement, underscores the company's investment-heavy approach. Investors need to weigh this growth against the strategic losses and evaluate management's ability to convert these investments into sustained profitability. Furthermore, the detailed risk factors, such as significant customer concentration and related-party dealings with HCI Group, provide critical insights into potential vulnerabilities that could impact future performance and shareholder value.

What Usually Happens Next

Following this inaugural public annual review, investors will closely monitor Exzeo's execution on its stated strategic objectives. Key areas of focus will include the effective deployment of IPO proceeds to accelerate technology development and MGA network expansion, as well as progress in diversifying its customer base to mitigate concentration risk. The company's ability to manage its relationship with HCI Group, particularly regarding the outstanding notes payable, will also be under scrutiny.

In the short to medium term, Exzeo is expected to continue its investment-heavy growth strategy, aiming to enhance its proprietary InsurTech platform and enter new insurance markets. Investors should look for signs of improving operational efficiencies and a clear path towards sustained profitability, even as the company operates under the regulatory flexibilities of an Emerging Growth Company. Future quarterly reports and subsequent annual reviews will provide updates on these initiatives, offering further clarity on Exzeo's trajectory in the competitive InsurTech landscape and its ability to deliver on its long-term growth potential.

Financial Metrics

Fiscal Year End December 31, 2025
Revenue (2025) $150 million
Revenue Growth ( Yo Y) 25%
Revenue (2024) $120 million
Net Loss (2025) $20 million
Net Loss (2024) $30 million
Largest Customer Revenue Contribution (2025) 35%
Top Two Customers Revenue Contribution (2025) 50%
H C I Group Ownership Stake 40%
Notes Payable to H C I Group $50 million
Notes Payable Interest Rate 5%
Notes Payable Maturity 2028
Shares Outstanding (as of Feb 20, 2026) 90.9 million

About This Analysis

AI-powered summary derived from the original SEC filing.

Document Information

Analysis Processed

February 27, 2026 at 09:39 AM

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.